# Leukine

NDC: 71837-5843
Generic name: SARGRAMOSTIM
Labeler / Manufacturer: Partner Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20230901

FDA application: BLA103362

## Active ingredients

- SARGRAMOSTIM: 250 ug/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71837-5843"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71837-5843
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bb9a3820-f31a-4dd9-bef4-97094c01a398